ERBB2 and ovarian cancer: Dual fluorescence and MRI contrast are provided by HER2-targeted gold nanoshell complexes, while NIR photothermal ablation of HER2-overexpressing, drug-resistant OVCAR3 ovarian cancer cells is enabled in vitro [109].